May 30, 2018
Kowa is finally rolling out its hyperlipidemia treatment Parmodia (pemafibrate) on June 1 after taking a pass on three rounds of price listing since its approval nearly a year ago. Parmodia, a successor to the company’s statin star Livalo (pitavastatin),...read more